Insights

Target need Membrane protein targets represent the majority of drug targets; CALIXAR preserves native structure during extraction to enable high quality targets for structure-based drug design and high-throughput screening, presenting an opportunity to sell specialized protein isolation services to pharma and biotech R&D teams.

Strategic partnership Recent acquisition by Eurofins Discovery signals enhanced credibility and access to broader pharma networks; position as a premium provider of native membrane proteins within a larger discovery services ecosystem to win multi-year, integrated collaboration deals.

Diverse channels CALIXAR engages distributors and marketplaces (Scientist.com), indicating multiple go‑to‑market routes; leverage distributor relationships and platform partnerships to accelerate sales of proteins, assay-ready targets, and customized crystallization services.

Technology edge Specialized chemistry and biochemistry tools for isolating full-length membrane proteins with functional integrity provide a compelling value proposition for clients pursuing SB/HTS programs, vaccines, and biologics; upsell to teams needing high-purity targets with minimal structural alteration.

Growth enablers Small team size with focused niche capabilities and a clear services/biz model (fee-for-service, risk sharing, exclusivity, licensing) suggests opportunities to scale via add-on services, expanded target panels, and joint RD programs with larger pharma partners seeking access to high-quality membrane proteins.

Similar companies to Eurofins CALIXAR

Eurofins CALIXAR Tech Stack

Eurofins CALIXAR uses 8 technology products and services including Hotjar, HubSpot Analytics, Amazon Web Services, and more. Explore Eurofins CALIXAR's tech stack below.

Eurofins CALIXAR's Email Address Formats

Eurofins CALIXAR uses at least 2 email formats:
Eurofins CALIXAR Email FormatsExamplePercentage
FLast@calixar.comJDoe@calixar.com
94%
LastFir@calixar.comDoeJoh@calixar.com
6%

Frequently Asked Questions

What is Eurofins CALIXAR's phone number?

Minus sign iconPlus sign icon
You can contact Eurofins CALIXAR's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Eurofins CALIXAR's official website and social media links?

Minus sign iconPlus sign icon
Eurofins CALIXAR's official website is calixar.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Eurofins CALIXAR generate?

Minus sign iconPlus sign icon
As of November 2026, Eurofins CALIXAR's annual revenue is estimated to be <$1M.

What is Eurofins CALIXAR's SIC code and NAICS code?

Minus sign iconPlus sign icon
Eurofins CALIXAR's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eurofins CALIXAR have currently?

Minus sign iconPlus sign icon
As of November 2026, Eurofins CALIXAR has approximately 10 employees across 1 continents, including Europe. Key team members include Co-Founder Of The Calixar Company: P. F., Marketing Director, Europe: G. D. and Scientific Director: K. K. Explore Eurofins CALIXAR's employee directory with LeadIQ.

What industry does Eurofins CALIXAR belong to?

Minus sign iconPlus sign icon
Eurofins CALIXAR operates in the Biotechnology Research industry.

What technology does Eurofins CALIXAR use?

Minus sign iconPlus sign icon
Eurofins CALIXAR's tech stack includes Hotjar, HubSpot Analytics, Amazon Web Services, WordPress, Cookiebot, Webflow, PayPal and Bootstrap.

What is Eurofins CALIXAR's email format?

Minus sign iconPlus sign icon
Eurofins CALIXAR's email format typically follows the pattern of FLast@calixar.com. Find more Eurofins CALIXAR email formats with LeadIQ.

How much funding has Eurofins CALIXAR raised to date?

Minus sign iconPlus sign icon
As of November 2026, Eurofins CALIXAR has raised $2.2M in funding. The last funding round occurred on Feb 24, 2015 for $1.1M.

When was Eurofins CALIXAR founded?

Minus sign iconPlus sign icon
Eurofins CALIXAR was founded in 2011.
Eurofins CALIXAR logo

Eurofins CALIXAR

Biotechnology ResearchAuvergne-Rhône-Alpes, France2-10 Employees

Eurofins CALIXAR is a biotechnology research company based in Lyon, in the Auvergne-Rhône-Alpes region of France. It specializes in isolating membrane proteins and antigens in states that preserve their native structure and function, delivering full-length targets in solution to support downstream drug discovery efforts. This capability enables pharmaceutical developers to work with high-quality targets for antibody discovery, vaccine formulation, and structure-based drug design or high-throughput screening, aiming to reduce development time and risk. 
The company serves biotechs, academic teams, and pharmaceutical organizations seeking accurate membrane targets to inform their research. CALIXAR offers flexible engagement options, including fee-for-service, risk-sharing, exclusivity, and licensing arrangements, reflecting varied customer needs. In 2023, CALIXAR was acquired by Eurofins Discovery Services, integrating its membrane-protein capabilities into a broader drug-discovery platform.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
2-10

Section iconFunding & Financials

  • $2.2M

    Eurofins CALIXAR has raised a total of $2.2M of funding over 2 rounds. Their latest funding round was raised on Feb 24, 2015 in the amount of $1.1M as a Series B.

  • <$1M

    Eurofins CALIXAR's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.